ArticleFunctional & integrative genomics2026
A multi-scale graph frequency network for structural and functional region analysis in spatial transcriptomics.
Article in Functional & integrative genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Spatial transcriptomics enables the systematic exploration of how gene expression patterns are organized within intact tissues, yet effective analysis remains difficult due to the complexity of spatial dependencies and multi-scale tissue architectures. Here, we present the Spatial Graph Frequency Network (SGFN), a deep learning framework that integrates graph signal processing, graph attention, and contrastive learning to jointly model spatial topology and molecular features. Central to SGFN is a frequency-domain enhancement module that decomposes spatial graphs into multi-scale spectral components using the Laplacian eigenbasis, complemented by adaptive wavelet denoising when the retained graph-frequency sequence length permits valid decomposition. Evaluation across diverse biological systems-including the human dorsolateral prefrontal cortex, mouse brain, human breast cancer, osmFISH, MERFISH, STARmap, mouse embryonic development, head and neck angiosarcoma, and brain metastasis-shows that SGFN achieves improved or competitive performance relative to representative baseline methods in reference-based benchmarks, and identifies biologically coherent spatial or functional regions in unlabeled datasets supported by marker-gene, spatial-autocorrelation, cell-type-colocalization, and pathway-enrichment evidence. SGFN accurately reconstructed cortical layer architecture in the human brain, delineated immune and metabolic modules in tumors, and revealed spatiotemporal trajectories during embryogenesis. By combining interpretable frequency-domain representations with data-driven learning, SGFN provides a unified computational framework for decoding tissue organization and molecular heterogeneity, advancing the understanding of developmental, physiological, and pathological spatial systems.
Indexed as
Identifiers
42402496What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.